Literature DB >> 89045

Plasma steroid and protein hormone concentrations in patients with benign prostatic hypertrophy and in normal men.

E Ortega, E Ruiz, M C Mendoza, A Martin-Andres, C Osorio.   

Abstract

Serum levels of testosterone, FSH, LH and prolactin were measured by RIA in patients with BPH (benign prostatic hypertrophy) and in control men. The testosterone concentrations in the BPH group were significantly lower than that of the control group. Serum concentrations of FSH, LH, prolactin and estradiol, did not differ significantly in the 2 groups.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 89045     DOI： 10.1007/BF01968288

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  16 in total

1.  A SEARCH FOR INHIBITORS OF PROSTATE GROWTH STIMULATORS.

Authors:  C TESAR; W W SCOTT
Journal:  Invest Urol       Date:  1964-03

2.  Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during oestrogen therapy.

Authors:  M E Harper; W B Peeling; T Cowley; B G Brownsey; M E Phillips; G Groom; D R Fahmy; K Griffiths
Journal:  Acta Endocrinol (Copenh)       Date:  1976-02

3.  Further studies on Leydig cell function in old age.

Authors:  R Rubens; M Dhont; A Vermeulen
Journal:  J Clin Endocrinol Metab       Date:  1974-07       Impact factor: 5.958

4.  [Studies on the causal genesis of prostatic hypertrophy. II].

Authors:  J Kaufmann
Journal:  Z Urol Nephrol       Date:  1968-04

5.  Age related changes and interrelationships between plasma testosterone, oestradiol and testosterone-binding globulin in normal adult males.

Authors:  K M Pirke; P Doerr
Journal:  Acta Endocrinol (Copenh)       Date:  1973-12

6.  Testosterone secretion and metabolism in male senescence.

Authors:  A Vermeulen; R Rubens; L Verdonck
Journal:  J Clin Endocrinol Metab       Date:  1972-04       Impact factor: 5.958

7.  The apparent free testosterone concentration, an index of androgenicity.

Authors:  A Vermeulen; T Stoïca; L Verdonck
Journal:  J Clin Endocrinol Metab       Date:  1971-11       Impact factor: 5.958

8.  [Testostérone and oestradiol17 beta production rates in a patient suffering fromhypertrophy of the prostate (author's transl)].

Authors:  F Bayard; J P Louvet; J L Thijssens; J P Thouvenot; C Boulard
Journal:  Ann Endocrinol (Paris)       Date:  1974 Sep-Oct       Impact factor: 2.478

9.  The isolation of progesterone from human pregnancy urine.

Authors:  A A Ismail; R A Harkness
Journal:  Acta Endocrinol (Copenh)       Date:  1967-10

10.  Altered blood androgens in elderly men with prostate hyperplasia.

Authors:  R Horton; P Hsieh; J Barberia; L Pages; M Cosgrove
Journal:  J Clin Endocrinol Metab       Date:  1975-10       Impact factor: 5.958
View more
  4 in total

1.  The effect of ergobromocriptine on serum testosterone and prolactin levels in patients with carcinoma of the prostate.

Authors:  C Taşar; A Akdaş; Z Kirkali
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370

2.  Spatiotemporal Proteomics Reveals the Molecular Consequences of Hormone Treatment in a Mouse Model of Lower Urinary Tract Dysfunction.

Authors:  Samuel Thomas; Ling Hao; Kellen DeLaney; Dalton McLean; Laura Steinke; Paul C Marker; Chad M Vezina; Lingjun Li; William A Ricke
Journal:  J Proteome Res       Date:  2020-03-16       Impact factor: 4.466

3.  Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.

Authors:  Alan R Kristal; Jeannette M Schenk; YoonJu Song; Kathryn B Arnold; Marian L Neuhouser; Phyllis J Goodman; Daniel W Lin; Frank Z Stanczyk; Ian M Thompson
Journal:  Am J Epidemiol       Date:  2008-10-21       Impact factor: 4.897

4.  Bisphenol A exposure during adulthood alters expression of aromatase and 5α-reductase isozymes in rat prostate.

Authors:  Beatriz Castro; Pilar Sánchez; Jesús M Torres; Ovidiu Preda; Raimundo G del Moral; Esperanza Ortega
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.